State of Practice: ASNR Statement on Gadolinium-Based Contrast Agent Use in Patients with Chronic Kidney Disease

Kirk M. Welker, David Joyner, Anthony W. Kam, David S. Liebeskind, Amit M. Saindane, Colin Segovis, Noushin Yahyavi-Firouz-Abadi and John E. Jordan

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in through your institution

Advertisement